David Reverter

63 papers and 2.5k indexed citations i.

About

David Reverter has authored 63 papers that have received a total of 2.5k indexed citations. This includes 57 papers in Molecular Biology, 29 papers in Oncology and 18 papers in Cell Biology. The topics of these papers are Ubiquitin and proteasome pathways (26 papers), Peptidase Inhibition and Analysis (21 papers) and Signaling Pathways in Disease (7 papers). David Reverter is often cited by papers focused on Ubiquitin and proteasome pathways (26 papers), Peptidase Inhibition and Analysis (21 papers) and Signaling Pathways in Disease (7 papers) and collaborates with scholars based in Spain, United States and Germany. David Reverter's co-authors include Francesc Avilés, Christopher D. Lima, Nathalia Varejão, Josep Vendrell and Salvador Ventura and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Fields of papers published by David Reverter

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

Countries citing papers authored by David Reverter

Since Specialization
Citations
Rankless by CCL
2025